Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats

Stem Cells Translational Medicine

Volumn 4, Issue 1, 2014, Pages 31-43

  Müller, Janine ^a   Ossig, Christiana ^b,c   Greiner, Johannes F W ^a   Hauser, Stefan ^a   Fauser, Mareike ^b,c   Widera, Darius ^a   Kaltschmidt, Christian ^a   Storch, Alexander ^b,c   Kaltschmidt, Barbara ^a  

^a BIELEFELD UNIVERSITY   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Adult stem cells; Cell transplantation; Nasal stem cells; Neural differentiation; Parkinson s disease

Indexed keywords

AMPHETAMINE; BETA TUBULIN; COLLAGENASE; MICROTUBULE ASSOCIATED PROTEIN 2;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL COUNTING; CIRCLING BEHAVIOR; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA SYNTHESIS; DOPAMINERGIC ACTIVITY; FEMALE; FLUORESCENCE MICROSCOPY; GLIA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; NERVE CELL DIFFERENTIATION; NEURAL CREST; NEURAL STEM CELL TRANSPLANTATION; NISSL STAINING; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; SYNAPSE VESICLE; TURBINATE; ULTRAVIOLET SPECTROPHOTOMETRY; ADULT STEM CELL; ANIMAL; CELL DIFFERENTIATION; CONVALESCENCE; CYTOLOGY; NEURAL STEM CELL; PARKINSONIAN DISORDERS; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION; WISTAR RAT; XENOGRAFT;

PARKINSONIA; RATTUS;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; FEMALE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; NEURAL CREST; NEURAL STEM CELLS; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

EID: 84919783125     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0078     Document Type: Article

References (81)

1. Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med 2003;348: 1356–1364.
2. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev 2011;91:1161–1218.
3. Gray F. The neuropathology of Parkinson syndrome. Rev Neurol (Paris) 198144: 229–248; [in French] [PubMed].
4. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374–379.
5. Krack P, Batir A, Van Blercom N et al. Fiveyear follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003;349:1925–1934.
6. Wolz M, Hauschild J, Koy J et al. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2012;18:994–997.
7. Love S, Plaha P, Patel NK et al. Glial cell line-derived neurotrophic factor induces neuronal sprouting inhumanbrain. Nat Med 2005;11: 703–704.
8. Kaplitt MG, Feigin A, Tang C et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: An open label, phase I trial. Lancet 2007;369:2097–2105.
9. Fabbrini G, Brotchie JM, Grandas F et al. Levodopa-induced dyskinesias. Mov Disord 2007;22:1379–1389; quiz 1523.
10. Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson’s disease? J Neurol 2005;252(suppl 4):IV37–IV42.
11. Lindvall O, Brundin P, Widner H et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science 1990;247:574–577.
12. Freed CR, Breeze RE, Rosenberg NL et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N Engl J Med 1992;327:1549–1555.
13. Spencer DD, Robbins RJ, Naftolin F et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N Engl J Med 1992;327:1541–1548.
14. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 2001;344:710–719.
15. Kriks S, Shim JW, Piao J et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 2011;480:547–551.
16. Erdö F, Bührle C, Blunk J et al. Hostdependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003;23:780–785.
17. Brederlau A, Correia AS, Anisimov SV et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: Effect of in vitro differentiation on graft survival and teratoma formation. STEM CELLS 2006;24:1433–1440.
18. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expressionsignature in poorly differentiatedaggressive human tumors. Nat Genet 2008;40:499–507.
19. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008;100:133–158.
20. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004;116:639–648.
21. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011;11: 268–277.
22. Ra JC, Shin IS, Kim SH et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011;20:1297–1308.
23. Wakitani S, Mitsuoka T, Nakamura N et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports. Cell Transplant 2004;13:595–600.
24. Kitoh H, Kitakoji T, Tsuchiya H et al. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 2007; 40:522–528.
25. Bonab MM, Sahraian MA, Aghsaie A et al. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: An open label study. Curr Stem Cell Res Ther 2012;7:407–414.
26. Schiavetta A, Maione C, Botti C et al. A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: Results of the Naples and Pietra Ligure Evaluation of Stem Cells study. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:572–578.
27. Wang Y, Yang J, Li H et al. Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson’s disease. PLoS One 2013;8:e54296.
28. Barzilay R, Kan I, Ben-Zur T et al. Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev 2008;17: 547–554.
29. Trzaska KA, Rameshwar P. Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol 2011;698:295–303.
30. Franco Lambert AP, Fraga Zandonai A, Bonatto D et al. Differentiation of human adipose-derived adult stem cells into neuronal tissue: Does it work? Differentiation 2009;77: 221–228.
31. Toma JG, Akhavan M, Fernandes KJ et al. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778–784.
32. Sieber-Blum M, Grim M, Hu YF et al. Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn 2004;231:258–269.
33. Sieber-Blum M, Schnell L, Grim M et al. Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord. Mol Cell Neurosci 2006;32:67–81.
34. Widera D, Zander C, Heidbreder M et al. Adult palatum as a novel source of neural crestrelated stem cells. STEMCELLS 2009;27:1899–1910.
35. Davies LC, Locke M, Webb RD et al. Amultipotent neural crest-derived progenitor cell population is resident within the oral mucosa lamina propria. Stem Cells Dev 2010;19:819–830.
36. Marynka-Kalmani K, Treves S, Yafee M et al. The lamina propria of adult human oral mucosa harbors a novel stem cell population. STEM CELLS 2010;28:984–995.
37. Seo BM, Miura M, Gronthos S et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149–155.
38. Widera D, Grimm WD, Moebius JM et al. Highly efficient neural differentiation of human somatic stem cells, isolated by minimally invasive periodontal surgery. Stem Cells Dev 2007; 16:447–460.
39. Kaltschmidt B, Kaltschmidt C, Widera D. Adult craniofacial stem cells: Sources and relation to the neural crest. Stem Cell Rev 2012;8: 658–671.
40. Greiner JF, Hauser S, Widera D et al. Efficient animal-serum free 3D cultivation method for adult human neural crest-derived stem cell therapeutics. Eur Cell Mater 2011;22:403–419.
41. Hauser S, Widera D, Qunneis F et al. Isolation of novel multipotent neural crest-derived stem cells from adult human inferior turbinate. Stem Cells Dev 2012;21:742–756.
42. Greiner JF, Grunwald LM, Müller J et al. Culture bag systems for clinical applications of adult human neural crest-derived stem cells. Stem Cell Res Ther 2014;5:34.
43. Hunt DP, Morris PN, Sterling J et al. A highly enriched niche of precursor cells with neuronal and glial potential within the hair follicle dermal papilla of adult skin. STEM CELLS 2008;26:163–172.
44. Kubo A, Yoshida T, Kobayashi N et al. Efficient generation of dopamine neuron-like cells from skin-derived precursors with a synthetic peptide derived from von Hippel-Lindau protein. Stem Cells Dev 2009;18:1523–1532.
45. Narytnyk A, Verdon B, Loughney A et al. Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem Cell Rev 2014;10:316–326.
46. Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson’s disease. BioEssays 2002;24:308–318.
47. Kehinde LO, Buraimoh-Igbo LA, Ude OU et al. Electronic rotameter for quantitative evaluationof rotationalbehaviour in rats afterunilateral lesions of the nigrostriatal dopamine system. Med Biol Eng Comput 1984;22:361–366.
48. Robinson TE, Becker JB. The rotational behavior model: Asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats. Brain Res 1983;264:127–131.
49. Hermann A, Loewenbrück KF, Boldt Ä et al. Lack of vascular endothelial growth factor receptor-2/Flk1 signaling does not affect substantia nigra development. Neurosci Lett 2013;553:142–147.
50. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: years of image analysis. Nat Methods 2012;9:671–675.
51. Hynes M, Porter JA, Chiang C et al. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 1995;15:35–44.
52. Wang MZ, Jin P, Bumcrot DA et al. Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat Med 1995;1:1184–1188.
53. Hefti F, Melamed E, Wurtman RJ. Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization. Brain Res 1980;195:123–137.
54. Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 2004;318:215–224.
55. Bjorklund LM, Sánchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002;99:2344–2349.
56. Baier PC, Schindehütte J, Thinyane K et al. Behavioral changes in unilaterally 6-hydroxydopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. STEM CELLS 2004;22:396–404.
57. Schwarz SC, Wittlinger J, Schober R et al. Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: Effect of immunosuppression with cyclosporine A. Parkinsonism Relat Disord 2006;12:302–308.
58. Sundberg M, Bogetofte H, Lawson T et al. Improved cell therapy protocols for Parkinson’s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. STEM CELLS 2013;31:1548–1562.
59. Hargus G, Cooper O, Deleidi M et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats. Proc Natl Acad Sci USA 2010;107:15921–15926.
60. Reinhardt P, Glatza M, Hemmer K et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One 2013;8:e59252.
61. Gesi M, Soldani P, Giorgi FS et al. The role of the locus coeruleus in the development of Parkinson’s disease. Neurosci Biobehav Rev 2000;24:655–668.
62. Cova L, Armentero MT, Zennaro E et al. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson’s disease. Brain Res 2010;1311:12–27.
63. Pavón-Fuentes N, Blanco-Lezcano L, Martínez-Martín L et al. Stromal cell transplant in the 6-OHDA lesion model. Rev Neurol 2004 39:326–334; [in Spanish] [PubMed].
64. Blandini F, Cova L, Armentero MT et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 2010;19:203–217.
65. Glavaski-Joksimovic A, Bohn MC. Mesenchymal stemcells and neuroregeneration in Parkinson’s disease. Exp Neurol 2013;247:25–38.
66. Redmond DE Jr., Bjugstad KB, Teng YD et al. Behavioral improvement in a primate Parkinson’s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 2007;104:12175–12180.
67. Kordower JH, Emborg ME, Bloch J et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 2000;290:767–773.
68. Gash DM, Zhang Z, Ovadia A et al. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996;380:252–255.
69. Bilang-Bleuel A, Revah F, Colin P et al. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci USA 1997;94:8818–8823.
70. Nosrat IV, Smith CA, Mullally P et al. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Eur J Neurosci 2004;19:2388–2398.
71. Agrawal AK, Shukla S, Chaturvedi RK et al. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson’s disease: A cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol Dis 2004;16:516–526.
72. Woodhall E, West AK, Chuah MI. Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res Mol Brain Res 2001;88:203–213.
73. Murrell W, Feron F, Wetzig A et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005;233:496–515.
74. Mackay-Sim A. Stem cells and their niche in the adult olfactory mucosa. Arch Ital Biol 2010;148:47–58.
75. Chen X, Katakowski M, Li Y et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: Growth factor production. J Neurosci Res 2002;69:687–691.
76. Ganz J, Arie I, Ben-Zur T et al. Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:375–386.
77. Hegarty SV, Spitere K, Sullivan AM et al. Ventral midbrain neural stem cells have delayed neurogenic potential in vitro. Neurosci Lett 2014;559:193–198.
78. Wachter B, Schürger S, Rolinger J et al. Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: Evidence for de-differentiation of resident astrocytes. Cell Tissue Res 2010;342: 147–160.
79. Mayor R, Theveneau E. The role of the non-canonical Wnt-planar cell polarity pathway in neural crest migration. Biochem J 2014;457: 19–26.
80. Takahashi Y, Sipp D, Enomoto H. Tissue interactions in neural crest cell development and disease. Science 2013;341:860–863.
81. Jeong JO, Han JW, Kim JM et al. Malignant tumor formation after transplantation of shortterm cultured bone marrow mesenchymal stem cells in experimentalmyocardial infarction and diabetic neuropathy. Circ Res 2011;108:1340–1347.